Medical Facilities (DR) Q4 2024 earnings summary

Executive summary

• Achieved strong operational and financial performance in 2024, with increases in income from operations, adjusted EBITDA, and net income year-over-year.

• Completed the sale of Black Hills Surgical Hospital, receiving $96.1 million in cash proceeds and strengthening the balance sheet.

• Ended 2024 with a cash position of $108.5 million and repaid the entire $16.0 million corporate credit facility.

• Returned significant capital to shareholders through share repurchases and dividends, totaling $126.2 million since 2022.

• Full-year results showed growth in income from operations, adjusted EBITDA, and net income despite a slight decline in surgical case volumes in Q4.

Financial highlights

• Full-year facility service revenue rose 1.1% to $331.5 million; income from operations grew 10.5% to $54.7 million (excluding goodwill impairment); adjusted EBITDA increased 7.3% to $71.4 million.

• Q4 facility service revenue declined 1.1% to $91.1 million due to lower surgical case volumes.

• Q4 income from operations fell 4.9% to $17.4 million; adjusted EBITDA down 2.8% to $21.7 million.

• Net income for 2024 nearly doubled to $56.8 million, up 96.9% year-over-year; Q4 net income up 158.3% to $36.0 million.

• Basic EPS for 2024 was $1.36, up 202.2% year-over-year.

Outlook and guidance

• Focus remains on operational excellence, quality of care, and optimizing shareholder returns.

• No significant ongoing impact expected from IV saline shortages; physician absences remain variable.

• Monitoring potential impacts from site neutrality legislation, though no immediate effects anticipated.